Saudi Arabia point of care diagnostics market size reached US$ 457 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 825 Million by 2032, exhibiting a growth rate (CAGR) of 6.80% during 2024-2032. The increasing incidence of chronic diseases, such as diabetes, cardiovascular diseases, and infectious diseases, which has fueled the demand for rapid and efficient diagnostic tools at the point of care, is driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2023 |
Forecast Years
|
2024-2032 |
Historical Years
|
2018-2023
|
Market Size in 2023 | US$ 457 Million |
Market Forecast in 2032 | US$ 825 Million |
Market Growth Rate (2024-2032) | 6.80% |
Point of care diagnostics (POC) refers to medical tests conducted near the patient, providing rapid results for immediate clinical decision-making. These tests are often performed outside traditional laboratory settings, such as in a doctor's office, clinic, or at the bedside. POC diagnostics offer advantages like quicker turnaround times, enabling prompt initiation of treatment, and improved patient outcomes. These tests cover a wide range of medical parameters, including blood glucose levels, cholesterol, infectious diseases, and pregnancy. Portable devices, such as handheld analyzers and lateral flow assays, are commonly used in POC testing. The accessibility and speed of POC diagnostics contribute to more efficient healthcare delivery, particularly in emergency situations or resource-limited settings, where immediate results can be crucial for timely interventions and personalized patient care.
The point of care diagnostics market in Saudi Arabia is propelled by several factors, beginning with the growing demand for rapid and accurate medical testing. In recent years, advancements in technology have significantly enhanced the development of innovative POC diagnostic devices. Additionally, the rising prevalence of infectious diseases and the need for timely diagnosis contribute to the expanding market. Furthermore, the regional emphasis on decentralizing healthcare services has spurred the adoption of POC diagnostics, enabling healthcare providers to make swift and informed decisions at the patient's bedside. Moreover, the increasing awareness among both healthcare professionals and patients about the benefits of early disease detection fuels the market's growth. The convenience and cost-effectiveness of POC testing further drive its widespread acceptance, particularly in resource-limited settings. Collaborations between industry players and research institutions play a pivotal role in fostering R&D activities to introduce novel diagnostic solutions. Regulatory initiatives to streamline the approval process for POC devices also contribute to market expansion. As a result, the regional POC diagnostics market continues to evolve, meeting the growing need for efficient, accessible, and timely healthcare solutions.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on product type, platform, prescription mode, and end user.
Product Type Insights:
The report has provided a detailed breakup and analysis of the market based on the product type. This includes blood-glucose monitoring kit, cardio-metabolic monitoring kit, pregnancy and fertility testing kit, infectious disease testing kit, cholesterol test strip, hematology testing kit, and others.
Platform Insights:
A detailed breakup and analysis of the market based on the platform have also been provided in the report. This includes lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and immunoassays.
Prescription Mode Insights:
The report has provided a detailed breakup and analysis of the market based on the prescription mode. This includes prescription-based testing and OTC testing.
End User Insights:
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes professional diagnostic centers, home care, research laboratories, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Northern and Central Region, Western Region, Eastern Region, and Southern Region.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Units | US$ Million |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Product Types Covered | Blood-Glucose Monitoring Kit, Cardio-Metabolic Monitoring Kit, Pregnancy and Fertility Testing Kit, Infectious Disease Testing Kit, Cholesterol Test Strip, Hematology Testing Kit, Others |
Platforms Covered | Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays |
Prescription Modes Covered | Prescription-based Testing, OTC Testing |
End Users Covered | Professional Diagnostic Centers, Home Care, Research Laboratories, Others |
Regions Covered | Northern and Central Region, Western Region, Eastern Region, Southern Region |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 3699 Five User License: US$ 4699 Corporate License: US$ 5699 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |